TLSI
TriSalus Life Sciences, Inc.
Next earnings Aug 10, 2026 · consensus $-0.16 EPS, $10.5M rev
Last earnings +0.4% on 2026-05-12
$4.37
▲ +5.05%$4.37▼ -21.82%
over 1Y
L $2.52EODHDH $7.50
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+5.0%
1W+7.1%
1M+35.7%
3M+11.5%
YTD-28.4%
1Y-21.8%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 11 analysts
Buy
Revenue grew 53.4% YoY; but unprofitable (net margin -86.9%).
TriSalus Life Sciences, Inc. shows $45.2M in FY2025 revenue (+53.4% YoY), a -86.9% net margin.
Sources: SEC EDGAR (CIK 0001826667, latest 10-Q filed 2026-05-12) · EODHD · as of 6/26/2026, 11:25:11 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.